Stock listing
NASDAQ:FBLG FibroBiologics, Inc. Stock
Home listing (NASDAQ) of FibroBiologics, Inc.
Follow FibroBiologics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:FBLG
$0.971 USD -0.029 (-2.9%)
Close on Oct 16, 2026
- Ticker
- NASDAQ:FBLG
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 14, 2026
FibroBiologics Announces Australian Patent Accepted for Cellular Blend for the Regeneration of Chondrocytes and Cartilage Cells in Degenerated Spinal Discs
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 19 slides
Latest news
Financings
Private placement of shares of common stock and accompanying warrants
Sep 17, 2026
Closed: US$500,000 raised · US$1.675 a share · Warrants at US$1.55 for 60 months
Buyers: Hamid Khoja, Ph.D. (298,508 shares of common stock and accompanying warrants to purchase up to 298,508 shares)
Insiders: The entire placement was purchased by Chief Scientific Officer Hamid Khoja, Ph.D.
Use of proceeds: General corporate purposes and working capital
Decks
Investor Presentation (September 2026)
Investor deck · 19 slides · September 2026
Investor Day (December 2023)
Investor day · 33 slides · December 2023
FibroBiologics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 59 in the last 12 months · 116 in all · newest Oct 14, 2026 · oldest 2024
- Decks
- 2 decks · latest September 2026
Where FibroBiologics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:FBLG · Home listing · This page | NASDAQ | United States | USD |
| BOATS:FBLG | BOATS | United States | USD |
| Frankfurt:SG00 | Frankfurt | Germany | EUR |
| Lang & Schwarz:A426UV | Lang & Schwarz | Germany | EUR |
| LS Exchange:A426UV | LS Exchange | Germany | EUR |
Log in to ask 6ix AI your own questions about FibroBiologics, Inc.